Polymorphisms in the gene encoding the voltage-dependent Ca2+ channel CaV2.3 (CACNA1E) are associated with type 2 diabetes and impaired insulin secretion
Polymorphisms in the gene encoding the voltage-dependent Ca2+ channel CaV2.3 (CACNA1E) are associated with type 2 diabetes and impaired insulin secretion
复制标题
DOI:
10.1007/s00125-007-0846-2
复制
发表时间:
2007-12-01
期刊:
影响因子:
8.2
通讯作者:
Groop, L.
中科院分区:
文献类型:
--
作者:
Holmkvist, J.;Tojjar, D.;Groop, L.
Aims/hypothesis Glucose-stimulated insulin secretion is dependent on the electrical activity of beta cells; hence, genes encoding beta cell ion channels are potential candidate genes for type 2 diabetes. The gene encoding the voltage-dependent Ca2+ channel Ca(V)2.3 (CACNA1E), telomeric to a region that has shown suggestive linkage to type 2 diabetes (1q21-q25), has been ascribed a role for second-phase insulin secretion.Methods Based upon the genotyping of 52 haplotype tagging single nucleotide polymorphisms (SNPs) in a type 2 diabetes case - control sample (n= 1,467), we selected five SNPs that were nominally associated with type 2 diabetes and genotyped them in the following groups (1) a new case - control sample of 6,570 individuals from Sweden; (2) 2,293 individuals from the Botnia prospective cohort; and (3) 935 individuals with insulin secretion data from an IVGTT.Results The rs679931 TT genotype was associated with (1) an increased risk of type 2 diabetes in the Botnia case - control sample [odds ratio (OR) 1.4, 95% CI 1.0 - 2.0, p= 0.06] and in the replication sample (OR 1.2, 95% CI 1.0-1.5, p= 0.01 one-tailed), with a combined OR of 1.3 (95% CI 1.1-1.5, p= 0.004 two-tailed); (2) reduced insulin secretion [insulinogenic index at 30 min p= 0.02, disposition index (D-I) p= 0.03] in control participants during an OGTT; ( 3) reduced second-phase insulin secretion at 30 min (p= 0.04) and 60 min (p= 0.02) during an IVGTT; and ( 4) reduced DI over time in the Botnia prospective cohort (p= 0.05).Conclusions/ interpretation We conclude that genetic variation in the CACNA1E gene contributes to an increased risk of the development of type 2 diabetes by reducing insulin secretion.